Alexandria Pharmaceuticals reports 31% profit drop in FY20/21 modified financials

Cairo – MubasherAlexandria Co. for Pharmaceuticals and Chemical Industries recorded net profits of EGP 116.99 million in fiscal year (FY) 2020/2021, down by 31.2% year-on-year (YoY) from EGP 170.05 million, the modified financial results showed. 

The sales increased to EGP 1.11 billion in the year ended 30 June from EGP 1.02 billion a year earlier, the company said in a bourse disclosure on Sunday. 

During the first nine months of FY20/21, Alexandria Co. for Pharmaceuticals and Chemical Industries achieved net profits of EGP 108.17 million, down from EGP 134.37 million in the year-ago period. 

Mubasher Contribution Time: 05-Sep-2021 11:43 (GMT)
Mubasher Last Update Time: 05-Sep-2021 11:43 (GMT)